Koszty Operacyjne Zmiana Data
AstraZeneca USD 12.53B 4.16B 2025-12
Autolus Therapeutics Ltd USD 92.82M 10.21M 2025-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Novartis USD 9.8B 61M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Silence Therapeutics USD 12.5M 13.91M 2025-12